Why the study?
What are the predictors of 90-day mortality in patients undergoing primary shoulder arthroplasty?
What are the predictors of 90-day mortality in patients undergoing primary shoulder arthroplasty?
90-day mortality after primary shoulder arthroplasty is generally low, but risk is significantly influenced by baseline comorbidities, ASA class, and underlying tumor diagnosis.
May inform preoperative risk discussions in shoulder arthroplasty; leaves open independent effects of tumor, comorbidity, ASA, and BMI.
90-day mortality following shoulder arthroplasty was low. An underlying diagnosis of tumor, higher comorbidity and higher ASA class were risk factors for higher 90-day mortality, while higher BMI was protective. Pre-operative comorbidity management may impact 90-day mortality following shoulder arthroplasty. A higher unadjusted mortality in patients undergoing TSA versus HHR may indicate the underlying differences in patients undergoing these procedures.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: